Chi-yuan Hsu
Dr. Chi-yuan Hsu was born and finished high school in Hong Kong. He is a graduate of Yale College and Harvard Medical School and completed his renal fellowship at the Massachusetts General Hospital. Dr. Hsu moved to the University of California, San Francisco in 1999 where he is currently the Dr. Robert W. Schrier Distinguished Professor in Nephrology and Chief of the Division of Nephrology.
In recognition of his research achievements, Dr. Hsu has been inducted into the American Society for Clinical Investigation and the Association of American Physicians. He received a Top 10 Clinical Research Achievement Award from the Clinical Research Forum in 2022. His Google Scholar H-index is 99.
A major focus of Dr. Hsu’s research has been the population epidemiology of acute kidney injury and the bidirectional relationship between acute kidney injury and chronic kidney disease. With Dr. Kathleen Liu, he co-led Liberation From Acute Dialysis (LIBERATE-D) randomized control trial (JAMA 2026) which showed that a conservative dialysis strategy promoted kidney function recovery in patients with severe dialysis-requiring acute kidney injury.
20th September 2026 Sunday
| Time | Session |
|---|---|
|
07:30
08:15
|
Targeting Persistent AKI and Promoting Recovery
Room 1
|
|
10:45
11:30
|
VinCent Wu
Moderator
AKD Care Redefined: Diabetes, Hypertension, and Strategies for Long-Term Health
Room 1
|